These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Sumatriptan: efficacy and contribution to migraine mechanisms. Pearce JM J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1103-5. PubMed ID: 1336041 [No Abstract] [Full Text] [Related]
5. SUMATRIPTAN: a receptor-targeted treatment for migraine. Moskowitz MA; Cutrer FM Annu Rev Med; 1993; 44():145-54. PubMed ID: 8386498 [TBL] [Abstract][Full Text] [Related]
6. 5-HT(1)-like receptor agonists and the pathophysiology of migraine. Saxena PR; Ferrari MD Trends Pharmacol Sci; 1989 May; 10(5):200-4. PubMed ID: 12722735 [TBL] [Abstract][Full Text] [Related]
7. Sumatriptan in acute migraine: pharmacology and review of world experience. Peroutka SJ Headache; 1990; 30 Suppl 2():554-60. PubMed ID: 2177047 [TBL] [Abstract][Full Text] [Related]
8. Sumatriptan: a new serotonin agonist for the treatment of migraine headache. Susman JL Am Fam Physician; 1993 Feb; 47(3):645-7. PubMed ID: 8382004 [TBL] [Abstract][Full Text] [Related]
9. Effect of sumatriptan on visual aura symptoms in migraine. Schoenen J Headache; 1993 Mar; 33(3):164. PubMed ID: 8387475 [No Abstract] [Full Text] [Related]
10. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. Dechant KL; Clissold SP Drugs; 1992 May; 43(5):776-98. PubMed ID: 1379152 [TBL] [Abstract][Full Text] [Related]
11. Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials. Tfelt-Hansen P Cephalalgia; 1993 Aug; 13(4):238-44. PubMed ID: 8397070 [TBL] [Abstract][Full Text] [Related]
12. Sumatriptan: new relief for migraine headaches. Holdcroft C Nurse Pract; 1993 Jul; 18(7):11, 14. PubMed ID: 8394559 [No Abstract] [Full Text] [Related]
13. Sumatriptan in the treatment of migraine. Ferrari MD Neurology; 1993 Jun; 43(6 Suppl 3):S43-7. PubMed ID: 8389011 [TBL] [Abstract][Full Text] [Related]
14. Effects of avitriptan, a new 5-HT 1B/1D receptor agonist, in experimental models predictive of antimigraine activity and coronary side-effect potential. Saxena PR; De Vries P; Wang W; Heiligers JP; Maassen vandenBrink A; Bax WA; Yocca FD Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):295-302. PubMed ID: 9050026 [TBL] [Abstract][Full Text] [Related]
15. The safety of sumatriptan in asthmatic migraineurs. Lloyd DK; Pilgrim AJ Cephalalgia; 1993 Jun; 13(3):201-4. PubMed ID: 8395345 [TBL] [Abstract][Full Text] [Related]
16. Subcutaneous sumatriptan does not abort attacks of chronic paroxysmal hemicrania (CPH). Dahlöf C Headache; 1993 Apr; 33(4):201-2. PubMed ID: 8388371 [No Abstract] [Full Text] [Related]
18. [Sumatriptan and its use in treatment of migraine and cluster headaches]. Prusiński A Neurol Neurochir Pol; 1992; Suppl 2():28-48. PubMed ID: 1337766 [TBL] [Abstract][Full Text] [Related]